Evommune EVMN Increase (Decrease) in Inventories
Increase (Decrease) in Inventories at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's increase (decrease) in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's increase (decrease) in inventories?
- Evommune (EVMN) reported increase (decrease) in inventories of $42.04K in Q1 2026.
- How has Evommune 's increase (decrease) in inventories changed year-over-year?
- Evommune 's increase (decrease) in inventories decreased by 62.2% year-over-year, from $111.14K to $42.04K.
- What does increase (decrease) in inventories mean?
- Reflects the net change in the value of raw materials, work-in-progress, and finished goods held by the company. Fluctuations indicate changes in production levels or demand expectations for the company's clinical or commercial products. Efficient management of this balance is critical to minimizing carrying costs and obsolescence risk.